SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
	Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person* CCP III Cayman GP Ltd. (Last) (First) (Middle) 375 PARK AVENUE, 13TH FLOOR (Street) NEW YORK NY 10152 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol GoHealth, Inc. [ GOCO ] Foreign Trading Symbol	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner Officer (give title below) Other (specify below)
	3. Date of Earliest Transaction (Month/Day/Year) 07/21/2026
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	07/21/2026		D(1)		4,179,850	D	(2)	0	I	See footnotes(3)(4)(5)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
LLC Interests of GoHealth Holdings, LLC	(6)	07/21/2026		D			5,386,178	(6)	(6)	Class A Common Stock	5,386,178	(2)	0	I	See footnotes(3)(4)(5)

1. Name and Address of Reporting Person* CCP III Cayman GP Ltd. (Last) (First) (Middle) 375 PARK AVENUE, 13TH FLOOR (Street) NEW YORK NY 10152 (City) (State) (Zip)

1. Name and Address of Reporting Person* Centerbridge Associates III, L.P. (Last) (First) (Middle) 375 PARK AVENUE, 13TH FLOOR (Street) NEW YORK NY 10152 (City) (State) (Zip)

1. Name and Address of Reporting Person* CCP III AIV VII Holdings, L.P. (Last) (First) (Middle) 375 PARK AVENUE, 13TH FLOOR (Street) NEW YORK NY 10152 (City) (State) (Zip)

1. Name and Address of Reporting Person* CB Blizzard Co-Invest Holdings, L.P. (Last) (First) (Middle) 375 PARK AVENUE, 13TH FLOOR (Street) NEW YORK NY 10152 (City) (State) (Zip)

1. Name and Address of Reporting Person* Blizzard Aggregator, LLC (Last) (First) (Middle) 375 PARK AVENUE, 13TH FLOOR (Street) NEW YORK NY 10152 (City) (State) (Zip)

1. Name and Address of Reporting Person* Aronson Jeffrey (Last) (First) (Middle) 375 PARK AVENUE, 13TH FLOOR (Street) NEW YORK NY 10152 (City) (State) (Zip)

1. Name and Address of Reporting Person* CB Blizzard Lower Holdings GP A, LLC (Last) (First) (Middle) 375 PARK AVENUE, 13TH FLOOR (Street) NEW YORK NY 10152 (City) (State) (Zip)

1. Name and Address of Reporting Person* CB Blizzard Lower Holdings A, L.P. (Last) (First) (Middle) 375 PARK AVENUE, 13TH FLOOR (Street) NEW YORK NY 10152 (City) (State) (Zip)

1. Name and Address of Reporting Person* CB Blizzard Lower Holdings GP B, LLC (Last) (First) (Middle) 375 PARK AVENUE, 13TH FLOOR (Street) NEW YORK NY 10152 (City) (State) (Zip)

1. Name and Address of Reporting Person* CB Blizzard Lower Holdings B, L.P. (Last) (First) (Middle) 375 PARK AVENUE, 13TH FLOOR (Street) NEW YORK NY 10152 (City) (State) (Zip)

Explanation of Responses:

1. On June 7, 2026, GoHealth, Inc. (the "Issuer"), GoHealth Holdings, LLC and certain of their direct and indirect subsidiaries filed voluntary petitions commencing cases under chapter 11 of title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware to implement a prepackaged Chapter 11 plan of reorganization (the "Plan"). The Plan became effective on July 21, 2026 (the "Effective Date"). Pursuant to the Plan, on the Effective Date, all of the Issuer's Class A common stock together with any shares of restricted stock, restricted stock units, or any other right to receive equity in the Issuer, in each case, outstanding immediately prior to the Effective Date, were cancelled, discharged and are of no force and effect.

2. Pursuant to the Plan, the holders of Class A common stock and other Allowed GoHealth Holding Interests (as defined in the Plan), including the reporting person, are entitled to receive their pro rata share of an approximately $10.3 million cash equity recovery pool.

3. Includes (i) 2,712,197 shares of Class A Common Stock previously held of record by CB Blizzard Lower Holdings A, L.P. ("CB Blizzard A") and (ii) 1,467,653 shares of Class A Common Stock previously held of record by CB Blizzard Holdings C, L.P. ("CB Blizzard C").

4. CCP III Cayman GP Ltd. ("CCP GP") is the general partner of CB Blizzard C and may be deemed to share beneficial ownership of the securities held of record by CB Blizzard C. CCP GP is also the general partner of Centerbridge Associates III, L.P., which is the general partner of each of CCP III AIV VII Holdings, L.P. and CB Blizzard Co-Invest Holdings, L.P., which are the owners of CB Blizzard Lower Holdings GP A, LLC, which is the general partner of CB Blizzard A. As a result, each of the foregoing entities may be deemed to share beneficial ownership of the securities held of record by CB Blizzard A. CCP GP is also the sole manager of Blizzard Aggregator, LLC, which is the owner of CB Blizzard Lower Holdings GP B, LLC, which is the general partner of CB Blizzard Lower Holdings B, L.P. ("CB Blizzard B"). As a result, each of the foregoing entities may be deemed to share beneficial ownership of the securities held of record by CB Blizzard B.

5. Jeffrey H. Aronson is the sole director of CCP GP and, as a result, may be deemed to share beneficial ownership of the securities held of record by each of CB Blizzard A, CB Blizzard C and CB Blizzard B. However, none of the foregoing should be construed in and of itself as an admission by Mr. Aronson or by any Reporting Person as to beneficial ownership of securities owned by another Reporting Person. In addition, Mr. Aronson expressly disclaims beneficial ownership of the securities held of record by each of CB Blizzard A, CB Blizzard C and CB Blizzard B, except to the extent of any proportionate pecuniary interest therein.

6. The LLC Interests of GoHealth Holdings, LLC were redeemable for an equal number of shares of Class A common stock.

Remarks:

Due to the limitations of the electronic filing system, CB Blizzard Holdings C, L.P. is filing on a separate Form 4.

	CCP III CAYMAN GP LTD. By: /s/ Susanne V. Clark, Authorized Signatory	08/17/2026
	CENTERBRIDGE ASSOCIATES III, L.P., By: CCP III CAYMAN GP LTD., its general partner, By: /s/ Susanne V. Clark, Authorized Signatory	08/17/2026
	CCP III AIV VII HOLDINGS, L.P., By: CENTERBRIDGE ASSOCIATES III, L.P., its general partner, By: CCP III CAYMAN GP LTD., its general partner, By: /s/ Susanne V. Clark, Authorized Signatory	08/17/2026
	CB BLIZZARD CO-INVEST HOLDINGS, L.P., By: CENTERBRIDGE ASSOCIATES III, L.P., its general partner, By: CCP III CAYMAN GP LTD., its general partner, By: /s/ Susanne V. Clark, Authorized Signatory	08/17/2026
	BLIZZARD AGGREGATOR, LLC, By: CCP III CAYMAN GP LTD., its sole manager, By: /s/ Susanne V. Clark, Authorized Signatory	08/17/2026
	JEFFREY H. ARONSON By: /s/ Jeffrey H. Aronson	08/17/2026
	CB BLIZZARD LOWER HOLDINGS GP A, LLC By: /s/ Susanne V. Clark, Authorized Signatory	08/17/2026
	CB BLIZZARD LOWER HOLDINGS A, L.P., By: CB BLIZZARD LOWER HOLDINGS GP A, LLC, its general partner, By: /s/ Susanne V. Clark, Authorized Signatory	08/17/2026
	CB BLIZZARD LOWER HOLDINGS GP B, LLC By: /s/ Susanne V. Clark, Authorized Signatory	08/17/2026
	CB BLIZZARD LOWER HOLDINGS B, L.P., By: CB BLIZZARD LOWER HOLDINGS GP B, LLC, its general partner, By: /s/ Susanne V. Clark, Authorized Signatory	08/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.